Healthcare and Medical Device

  According to the new market research report " Companion Diagnostics Market  by Product (Assays, Kits, Software & Services), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Blood, Lung, Colorectal Cancer, Neurology Diseases), End User (Pharma Companies, CROs), Region - Global Forecast to 2026 ", is projected to reach USD 9.9 billion by 2026 from USD 5.5 billion in 2021, at a CAGR of 12.6%. Browse and in-depth TOC on "Companion Diagnostics Market" 322 - Tables 51 - Figures 331 - Pages Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155571681 The large patient pool undergoing advanced medical testing, high drug development activity, structured regulatory framework in the region, and policy programs to provide effective care to patients with cancer are the major factors driving the market’s growth. Based on product & service, the companion diagnostics market is segmented into assays, kits& reagents, and software & s...